Original language | English |
---|---|
Pages (from-to) | 626-629 |
Number of pages | 4 |
Journal | Nature Medicine |
Volume | 28 |
Issue number | 4 |
DOIs |
|
State | Published - Apr 2022 |
Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery
Thomas U. Marron, Matthew D. Galsky, Bachir Taouli, Maria Isabel Fiel, Stephen Ward, Edward Kim, David Yankelevitz, Deborah Doroshow, Emma Guttman, Benjamin Ungar, Saurabh Mehandru, Benjamin J. Golas, Daniel Labow, John Sfakianos, Sujit S. Nair, Dimple Chakravarty, Michael Buckstein, Xiaoyu Song, Effi Kenigsberg, Sacha Gnjatic
- Human Immune Monitoring Center
- Cancer Clinical Investigation
- Icahn School of Medicine at Mount Sinai
- Marc and Jennifer Lipschultz Precision Immunology Institute
- Medicine
- Medicine - Hematology and Medical Oncology
- The Tisch Cancer Institute
- Graduate School of Biomedical Sciences
- Urology
- BioMedical Engineering and Imaging Institute
- Cancer/Body
- Friedman Brain Institute
- Liver Cancer
- Radiology (Diagnostic, Molecular and Interventional Radiology)
- Pathology, Molecular and Cell-Based Medicine
- Brain-Body Center
- Center for Inborn Errors of Immunity
- Waldman Department of Dermatology
- Medicine - Gastroenterology
- Surgery
- Radiation Oncology
- Institute for Healthcare Delivery Science
- Population Health Science and Policy
- Cancer Immunology
- Oncological Sciences
- Genetics and Genomic Sciences
- Icahn Genomics Institute
- Mindich Child Health and Development Institute
- Recanati Miller Transplantation Institute
Research output: Contribution to journal › Comment/debate
17
Scopus
citations